Skip to main content
Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.70
-1.10 (-12.50%)
May 5, 2025, 2:38 PM EDT - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Bioresorbable Hydrogel-based Formulation Technology
63.46M
Log In
Log In
Log In
Log In
Upgrade
Bioresorbable Hydrogel-based Formulation Technology Growth
9.66%
Log In
Log In
Log In
Log In
Upgrade
Collaboration
262.00K
Log In
Log In
Log In
Log In
Upgrade
Collaboration Growth
-54.28%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
63.72M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
9.03%
Log In
Log In
Log In
Log In
Upgrade